This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ernest Beutler, MD

Am J Dis Child. 1993;147(11):1175-1183.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Most physicians regard Gaucher's disease as a rare disorder, vaguely remembered among other esoteric diseases that they were forced to memorize as medical students. In point of fact, Gaucher's disease is the most common of the glycolipid storage disorders. The frequency of the disease genotype is about 1:1000 in the Ashkenazi Jewish population, the ethnic group in which it is most commonly found. The importance of understanding this disorder has been increased by recent developments that have simplified the diagnosis, made possible population-based screening, and provided an effective therapy for those patients who need it.

CLINICAL MANIFESTATIONS

Clinically, Gaucher's disease has been divided into three types. ¹ Type 1 is the most common form and is characterized by sparing of the central nervous system from the primary effects of glycolipid accumulation. The rare type 2 Gaucher's disease, in contrast, is an acute form with . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, Calif.

Footnotes
Accepted for publication June 14, 1993.

Reprint requests to Department of Molecular and Experimental Medicine, The Scripps Research Institute, 10666 N Torrey Pines Rd, La Jolla, CA 92037 (Dr Beutler).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?